Codexis is one of the leaders in the development of innovative bio-based solutions for pharmaceutical chemical process development and manufacturing. The company s unique protein and strain engineering technology platform creates superior biological catalysts either enzymes or fermentation strains crafted specifically for cutting-edge chemical processes that can enable pharmaceutical process development, shorten process development timelines and dramatically improve existing manufacturing processes. Codexis has more than 12 strategic alliances, including a major collaboration with Pfizer, and more than 20 products and processes in development internally and at leading worldwide life sciences companies. It began operations as an independent company in 2002. Codexis is headquartered in Redwood City, Calif.